HRS.15 Sessions to Attend
•
1 recomendación•1,015 vistas
This document provides a summary of 6 late-breaking sessions to attend at the Heart Rhythm Society Scientific Sessions in Boston from May 13-16, 2015. The sessions include: (1) a study on the impact of remote monitoring on clinical events and healthcare utilization; (2) a randomized global trial comparing uninterrupted rivaroxaban to vitamin K antagonists in patients undergoing catheter ablation; and (3) a study comparing cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation. The other sessions include: (4) first-in-human experience with a miniaturized transcatheter pacing system; (5) results from the Canadian Registry of Card
Recomendados
Recomendados
Más contenido relacionado
Similar a HRS.15 Sessions to Attend
Similar a HRS.15 Sessions to Attend (20)
Más de Trimed Media Group
Más de Trimed Media Group (20)
Último
Último (20)
HRS.15 Sessions to Attend
- 1. Top 6 Late-Breaking Sessions to Attend at HRS.15 Heart Rhythm Society Scientific Sessions Wednesday, May 13 — Saturday, May 16, 2015 Boston, Massachusetts
- 2. (1) Thursday, May 14 1:30–1:45 pm, Ballroom West Impact of Remote Monitoring on Clinical Events & Healthcare Utilization: A Nationwide Assessment Jonathan P. Piccini, MD Duke University Medical Center Durham, N.C.
- 3. (2) Thursday, May 14 1:45–2:00 pm, Ballroom West VENTURE-AF: A Randomized Global Trial Evaluating Uninterrupted Rivaroxaban & Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Nonvalvular Atrial Fibrillation Andrea Natale, MD Texas Cardiac Arrhythmia Institute Austin, Texas
- 4. (3) Thursday, May 14 2:00–2:15 pm, Ballroom West Cryoballoon versus Open Irrigated Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study Dr. Armin Luik Städtisches Klinikum Karlsruhe Karlsruhe, Germany
- 5. (4) Friday, May 15 8:00–8:15 am, Ballroom West Performance of a Miniaturized Transcatheter Pacing System: First in-human Experience Philippe Ritter, MD Hopital Haut-Leveque Pessac, France
- 6. (5) Friday, May 15 8:30–8:45 am, Ballroom West Canadian Registry of Cardiac Implantable Electronic Device Outcomes: Phase 1 Riata Lead on Advisory (CREDO) Ratika Parkash, MD Queen Elizabeth II Health Sciences Centre at Dalhousie University Halifax, Nova Scotia
- 7. (6) Friday, May 15 9:15–9:30 am, Ballroom West Visually Guided Laser Balloon (VGLB) Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF): Results of the Prospective Multicenter Randomized Heartlight Study Vivek Y. Reddy, MD, Mount Sinai School of Medicine, New York, N.Y.